Skip to content
Trial Eligibility
Menu

Acute Infection in Mitochondrial Disease: Metabolism, Infection and Immunity

NCT04419870

This study is recruiting at 1 US site in 1 state, according to its ClinicalTrials.gov record last updated .

Summary

Background: Mitochondrial disease is a rare disorder. It can cause poor growth, developmental delays, muscle weakness, and other symptoms. The disease is usually inherited. It can be present at birth or develop later in life. Infection is a major cause of disease and death in people with this disease. Researchers want to learn more about these infections and the declining health of people who have this disease. To do this, researchers will study the DNA of people who become ill. Their DNA will be compared to the DNA of their household/family members.

Shortened from the sponsor's brief summary. View official record on ClinicalTrials.gov

Conditions studied

  • Mitochondrial Disease

Eligibility basics and study details

Study type
Observational
Phase
Not applicable
Ages
2 months to 115 years
Sex
All
Healthy volunteers
Accepted
Sponsor
National Human Genome Research Institute (NHGRI)
Last updated on ClinicalTrials.gov
September 10, 2026

These are the basic criteria only. The full inclusion and exclusion criteria are on the official record, and the study team decides who can take part.

US recruiting sites

Maryland · 1

  • National Institutes of Health Clinical Center · Bethesda, MD

Source: ClinicalTrials.gov, data processed . Recruiting US sites filtered by distance and site status; summaries shortened.